WEBINAR ON DEMAND
Duration: 1 hour

​
The transformation healthcare delivery has experienced over the past decade accelerated dramatically in 2020. Telemedicine, once limited to rural communities, is now everywhere. Gene sequencing is helping researchers develop vaccines in record time. And patients and providers are turning to digital health apps and wearables as ways to monitor symptoms and vital signs.

Falling in line with the current “digital health revolution,” companies are taking more decisive steps to incorporate digital solutions into their product lines. But it’s not simple. And regulatory guidance doesn’t provide easy answers. This webinar will provide critical regulatory insights for commercial leaders developing digital health solutions. Webinar highlights include:

• The difference between a regulated and unregulated Internet of Things (IoT) infrastructure
• When (and why) digital health products need a regulated platform
• How using a regulated platform from the outset can prevent future problems
• The regulatory landscape for digital health and Software-as-a-Medical Device (SaMD)

SPEAKERS  

Kal Patel, MD
CEO & Co-Founder 
BrightInsight

Elisabethann Wright
Partner, EU Life Sciences
Hogan Lovells International

Prasad Peri
Senior Director Global Regulatory Affairs CMC
Teva Pharmaceuticals